[Effect of the liver X receptor agonist on LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB]

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Kupffer cells are key players in liver inflammation.
• Lipopolysaccharide (LPS) is a potent inducer of inflammatory responses.
• Interleukin-1 receptor-associated kinase 4 (IRAK-4) and Nuclear Factor-kappaB (NF-kappaB) are critical mediators of inflammation.

Purpose of the Study:

• To investigate the impact of activated liver X receptor (LXR) on IRAK-4 and NF-kappaB expression and activity.
• To determine the role of LXR in modulating LPS-induced inflammation in Kupffer cells.

Main Methods:

• Kupffer cells were isolated from mice.
• Cells were treated with LPS, an LXR agonist (T0901317), or both.
• Gene and protein expression of LXR, IRAK-4, and NF-kappaB were analyzed using real-time PCR and Western blot.
• NF-kappaB activity was assessed by Electrophoretic Mobility Shift Assay (EMSA).

Main Results:

• LXR agonist treatment significantly increased LXR mRNA and protein levels.
• Combined treatment with LPS and LXR agonist markedly reduced IRAK-4 and NF-kappaB mRNA and protein levels compared to LPS alone.
• NF-kappaB activity was highest in the LPS group and reduced by LXR agonist treatment.

Conclusions:

• LXR agonists effectively up-regulate LXR expression.
• LXR activation suppresses the expression of IRAK-4 and NF-kappaB.
• LXR agonists inhibit NF-kappaB activity, suggesting a role in mitigating inflammatory responses.